Text Messaging for Smoking Cessation in College Health Clinics

Cigarette Smoking Clinical Trial

Official title:

Text Messaging to Augment Physician Brief Advice for Smoking Cessation in College Health Clinics

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02191033
• Other study ID #: 1404013813
• Status: Completed
• Phase: N/A
• Start date: January 2015
• Est. completion date: August 2016

Study information

• Verified date: March 2020
• Source: Yale University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study is a randomized-controlled clinical trial which evaluates the efficacy of physician brief advice, nicotine replacement therapy and a 6-week course of text messaging in promoting cigarette smoking in smokers enrolled in college.

The primary hypothesis is that smokers receiving physician brief advice, nicotine replacement therapy, and text messaging will have higher quit rates that smokers receiving physician brief advice and nicotine replacement therapy alone.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: August 2016
• Est. primary completion date: May 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 24 Years

Eligibility

Inclusion Criteria:

• Aged 18 through 24 years

• Enrolled as a full/part time college student

• A current smoker (Have smoked more than 100 cigarettes in their lifetime and now smoke every day or some days)

• English-speaking

• Interested in quitting

• Have a cell phone for personal use with an unlimited text messaging plan.

Exclusion Criteria:

• History of hypersensitivity/allergy to nicotine patch;

• Serious arrhythmias - History of heart disease (myocardial infarction, severe chest pain, or coronary artery disease)

• Current pregnancy/breastfeeding/plan for pregnancy

Related Conditions & MeSH terms

• Cigarette Smoking

Intervention

Behavioral:
• Smoking counseling

• Text messaging

Drug:
• Nicotine patch

Locations

Country	Name	City	State
United States	Southern Connecticut State University	New Haven	Connecticut

Sponsors (3)

Lead Sponsor	Collaborator
Yale University	Southern Connecticut State University, University of New Haven

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Study Enrollment- Number of Participants Who Join the Study	We will report the number of persons who join the study.	baseline
Primary	Study Retention- Number of Participants Who Attend the 6- and 12-week Follow up Visits.	We will determine the number of enrolled participants who follow up at the 6- and 12- week follow up visit.	6- and 12- weeks
Secondary	Smoking Abstinence	biochemically confirmed point prevalence of self reported past 7-day abstinence	6- and 12- weeks